All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial - Huang, Q S; Liu, Y; Wang, J B (Lancet Haematol, 2021)